Publisher: John Wiley & Sons Inc
E-ISSN: 1097-4644|116|7|1205-1212
ISSN: 0730-2312
Source: JOURNAL OF CELLULAR BIOCHEMISTRY, Vol.116, Iss.7, 2015-07, pp. : 1205-1212
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
ABSTRACTMesenchymal stromal cells (MSCs) are promising candidate donor cells for replacement of cardiomyocyte loss during ischemia and in vitro generation of myocardial tissue. We have successfully isolated MSCs from the discarded neonatal thymus gland during cardiac surgery. The thymus MSCs were characterized by cell‐surface antigen expression. These cells have high ability for proliferation and are able to differentiate into osteoblasts and adipocytes in vitro. For cardiac differentiation, the cells were divided into 3 groups: untreated control; 5‐azacytidine group and sequential exposure to 5‐azacytidine, bone morphogenetic protein 4, and basic fibroblast growth factor. Thymus MSCs showed a fibrolast‐like morphology and some differentiated cells increased in size, formed a ball‐like appearance over time and spontaneously contracting cells were observed in sequential exposure group. Immunostaining studies, cardiac specific genes/protein expression confirmed the cardiomyocyte phenotype of the differentiated cells. These results demonstrate that thymus MSCs can be a promising cellular source for cardiac cell therapy and tissue engineering. J. Cell. Biochem. 116: 1205–1212, 2015. © 2014 Wiley Periodicals, Inc.
Related content
Isolation of Mesenchymal Stromal Cells (MSCs) from Human Adenoid Tissue
Cellular Physiology and Biochemistry, Vol. 31, Iss. 4-5, 2013-04 ,pp. :